01.02.2010 • News

ECHA’s RAC Adopts Opinions on Classification and Labeling Proposals

The Committee for Risk Assessment (RAC) of ECHA has adopted opinions on the proposals for classification and labellng across Europe of three chemical substances as carcinogen, mutagen or toxic for reproduction The substances are:

• Indium phosphide: The classification is currently not harmonized at EU level. RAC agreed with the proposal from France that the classification of the substance should be harmonized as a carcinogen and toxic for reproduction. RAC also proposed a classification for repeated dose toxicity from inhalation exposure. Indium phosphide is, for example, used as a semiconductor in the electronics industry.

• Di-tert-butyl peroxide - DTBP: DTBP is currently classified at EU level for certain physico-chemical hazards. RAC agreed with the proposal from France to also classify it as a mutagen. DTBP is typically used by industry as an additive in polymerisation reactions.

• Trixylyl phosphate: The classification is currently not harmonised at EU level. RAC agreed with the proposal from the Netherlands for a harmonised classification of toxic for reproduction. Trixylyl phosphate is mainly used as a fire resistant hydraulic fluid, for example in industrial power generators.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read